These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11436175)

  • 1. Preliminary report: Amino acid profile in platelets of diabetic patients.
    De Luca G; Calpona PR; Caponetti A; Macaione V; Di Benedetto A; Cucinotta D; Di Giorgio RM
    Metabolism; 2001 Jul; 50(7):739-41. PubMed ID: 11436175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taurine and osmoregulation: platelet taurine content, uptake, and release in type 2 diabetic patients.
    De Luca G; Calpona PR; Caponetti A; Romano G; Di Benedetto A; Cucinotta D; Di Giorgio RM
    Metabolism; 2001 Jan; 50(1):60-4. PubMed ID: 11172476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Follow-up of blood and urinary amino acid concentrations in diabetic ketoacidosis in children].
    Szabó A; Kenesei E; Miltényi M; Körner A; Szücs L; Nagy I
    Orv Hetil; 1990 Mar; 131(12):615-9. PubMed ID: 2108399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus.
    Jenkins AJ; Gosmanova AK; Lyons TJ; May KD; Dashti A; Baker MZ; Olansky L; Aston CE; Dale GL
    Diabetes Res Clin Pract; 2008 Aug; 81(2):e8-10. PubMed ID: 18508150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes.
    Wijekoon EP; Skinner C; Brosnan ME; Brosnan JT
    Can J Physiol Pharmacol; 2004 Jul; 82(7):506-14. PubMed ID: 15389298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone.
    Randriamboavonjy V; Pistrosch F; Bölck B; Schwinger RH; Dixit M; Badenhoop K; Cohen RA; Busse R; Fleming I
    Circulation; 2008 Jan; 117(1):52-60. PubMed ID: 18071073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acids for dialysis patients.
    Mastroiacovo P; Pace V; Sagliaschi G
    Clin Ther; 1993; 15(4):698-704. PubMed ID: 8221820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial glucose in skeletal muscle of diabetic patients during an oral glucose tolerance test.
    Frossard M; Blank D; Joukhadar Ch; Bayegan K; Schmid R; Luger A; Müller M
    Diabet Med; 2005 Jan; 22(1):56-60. PubMed ID: 15606692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent changes in the plasma amino acid concentration in diabetes mellitus.
    Mochida T; Tanaka T; Shiraki Y; Tajiri H; Matsumoto S; Shimbo K; Ando T; Nakamura K; Okamoto M; Endo F
    Mol Genet Metab; 2011 Aug; 103(4):406-9. PubMed ID: 21636301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal platelet function, but increased platelet activation in vivo in diabetic patients.
    Tomaselli L; Cerletti C; de Gaetano G; Notarbartolo A; Davì G; Pupillo M
    Thromb Haemost; 1990 Dec; 64(4):604. PubMed ID: 2128141
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron-binding antioxidant capacity is impaired in diabetes mellitus.
    Van Campenhout A; Van Campenhout C; Lagrou AR; Moorkens G; De Block C; Manuel-y-Keenoy B
    Free Radic Biol Med; 2006 May; 40(10):1749-55. PubMed ID: 16678014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-thalassemia major and its effect on amino acid metabolism and growth in patients in the United Arab Emirates.
    Abdulrazzaq YM; Ibrahim A; Al-Khayat AI; Dawson K
    Clin Chim Acta; 2005 Feb; 352(1-2):183-90. PubMed ID: 15653113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary antioxidants in patients with type 1 or 2 diabetes and inflammatory periodontal disease: a case-control study.
    Gümüş P; Buduneli N; Cetinkalp S; Hawkins SI; Renaud D; Kinane DF; Scott DA
    J Periodontol; 2009 Sep; 80(9):1440-6. PubMed ID: 19722794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-standing diabetes in Africa and recent ideas about advanced glycation end products: 39 patients in Dakar].
    Sidibé el H
    Sante; 2007; 17(1):23-7. PubMed ID: 17897898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus.
    Signorello MG; Viviani GL; Armani U; Cerone R; Minniti G; Piana A; Leoncini G
    Thromb Res; 2007; 120(4):607-13. PubMed ID: 17188741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of type I and type II diabetes mellitus on phenytoin steady-state levels.
    Adithan C; Srinivas B; Indhiresan J; Shashindran CH; Bapna JS; Thakur LC; Swaminathan RP
    Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):310-3. PubMed ID: 1743805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The S1P(2) receptor expressed in human platelets is linked to the RhoA-Rho kinase pathway and is down regulated in type 2 diabetes.
    Randriamboavonjy V; Badenhoop K; Schmidt H; Geisslinger G; Fisslthaler B; Fleming I
    Basic Res Cardiol; 2009 May; 104(3):333-40. PubMed ID: 19139947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid and lipoprotein profiles in Ethiopian patients with diabetes mellitus.
    Siraj ES; Seyoum B; Saenz C; Abdulkadir J
    Metabolism; 2006 Jun; 55(6):706-10. PubMed ID: 16713427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.